Date of this Version


Document Type

Journal Article

Publication Details

Accepted Version.

Jefferson, T., Jones, M., Doshi, P. & Del Mar, C. (2009). Possible harms of oseltamivir—A call for urgent action. The lancet, 374(9698), 1312-1313.

Access the publisher's website.

© Copyright Elsevier Ltd, 2009



Oseltamivir is a successful drug: between July, 2004, and June, 2009, more than 11·5 million new prescriptions were issued in the USA, and nearly all influenza pandemic plans recommend antiviral drugs as a mainstay of containment on a population basis and treatment on an individual basis, with oseltamivir preferred because of ease of administration and storage. Because 75% of the world production of oseltamivir has been used in Japan,¹ this is where to look for any serious harms the drug might cause.

¹ See note in article.



This document has been peer reviewed.


To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.